D-Nome

About D-Nome

D-Nome is a health-tech startup utilizing cell-free synthetic biology to provide rapid and accurate molecular diagnostics. Their technology enables scalable diagnostic solutions, addressing the need for accessible and efficient testing in healthcare.

```xml <problem> Current molecular diagnostic methods often lack the speed, accuracy, and scalability needed for widespread and efficient testing, particularly in resource-limited settings. Traditional diagnostic techniques can be complex, time-consuming, and require specialized laboratory infrastructure. </problem> <solution> D-Nome is developing cell-free synthetic biology-based diagnostics to enable rapid and accurate molecular testing. Their technology aims to democratize molecular diagnostics by providing scalable solutions that can be deployed in various settings. The core technology, D-LAMP, is an enzyme mix that facilitates rapid and accurate diagnostic results. This approach simplifies the diagnostic process, potentially reducing the need for extensive laboratory equipment and skilled personnel. </solution> <features> - Cell-free synthetic biology platform for molecular diagnostics - D-LAMP enzyme mix for rapid and accurate results - Scalable diagnostic solutions suitable for diverse settings </features> <target_audience> The primary target audience includes healthcare providers, diagnostic kit manufacturers, and research institutions seeking accessible and efficient molecular diagnostic solutions. </target_audience> ```

What does D-Nome do?

D-Nome is a health-tech startup utilizing cell-free synthetic biology to provide rapid and accurate molecular diagnostics. Their technology enables scalable diagnostic solutions, addressing the need for accessible and efficient testing in healthcare.

Where is D-Nome located?

D-Nome is based in Hyderabad, Pakistan.

When was D-Nome founded?

D-Nome was founded in 2021.

How much funding has D-Nome raised?

D-Nome has raised $1.6M.

Location
Hyderabad, Pakistan
Founded
2021
Funding
$1.6M
Employees
6 employees
Investors
Ankur CapitalCampus FundEntrepreneurs First3i PartnersYourcampus Fund

D-Nome

10
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

D-Nome is a health-tech startup utilizing cell-free synthetic biology to provide rapid and accurate molecular diagnostics. Their technology enables scalable diagnostic solutions, addressing the need for accessible and efficient testing in healthcare.

dnome.in1K+
Founded 2021Hyderabad, Pakistan

Funding

No specific funding rounds found.

Total Funding

$1.6M

Backed by

Entrepreneurs First3i PartnersAnkur CapitalCampus FundEntrepreneur First

Team (5+)

No team information available.

Company Description

Problem

Current molecular diagnostic methods often lack the speed, accuracy, and scalability needed for widespread and efficient testing, particularly in resource-limited settings. Traditional diagnostic techniques can be complex, time-consuming, and require specialized laboratory infrastructure.

Solution

D-Nome is developing cell-free synthetic biology-based diagnostics to enable rapid and accurate molecular testing. Their technology aims to democratize molecular diagnostics by providing scalable solutions that can be deployed in various settings. The core technology, D-LAMP, is an enzyme mix that facilitates rapid and accurate diagnostic results. This approach simplifies the diagnostic process, potentially reducing the need for extensive laboratory equipment and skilled personnel.

Features

Cell-free synthetic biology platform for molecular diagnostics

D-LAMP enzyme mix for rapid and accurate results

Scalable diagnostic solutions suitable for diverse settings

Target Audience

The primary target audience includes healthcare providers, diagnostic kit manufacturers, and research institutions seeking accessible and efficient molecular diagnostic solutions.

Sources:

This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.